OS THERAPIES INCORPORATED Accrued Liabilities, Current
OS THERAPIES INCORPORATED (OSTX) had Accrued Liabilities, Current of $1.42 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-03-31
- 2025-12-31: Accrued Liabilities, Current $1.42M.
- 2025-09-30: Accrued Liabilities, Current $395.45K.
- 2025-06-30: Accrued Liabilities, Current $380.31K.
- 2025-03-31: Accrued Liabilities, Current $364.41K.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2025-12-31 | $1.42M 10-K · filed 2026-03-31 |
| 2025-09-30 | $395.45K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $380.31K 10-Q · filed 2025-08-18 |
| 2025-03-31 | $364.41K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $521.01K 10-K · filed 2026-03-31 |
| 2024-09-30 | $296.40K 10-Q · filed 2024-11-15 |
| 2024-06-30 | $187.50K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $162.50K 10-Q · filed 2024-05-20 |
| 2023-12-31 | $162.50K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |